ConductScience.org, home

Paper · 42272085

A Bayesian-Based Integrative Bioinformatics Analysis Nominates Oncogenic Drivers in Neuroblastoma.

Xu L and 14 others. Clin Transl Sci, 2026. Cited by 1 paper, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. A Bayesian-Based Integrative Bioinformatics Analysis Nominates Oncogenic Drivers in Neuroblastoma. Papers, record 42272085. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42272085

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A Bayesian-Based Integrative Bioinformatics Analysis Nominates Oncogenic Drivers in Neuroblastoma.
PubMed
Journal
Clin Transl Sci
PubMed
Year
2026
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
1
iCite
Revised in PubMed
2026-08-20
PubMed

Authors15

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
NeuroblastomaMajor topic
OncogenesMajor topic
Computational BiologyMajor topic
Humans
Bayes Theorem
Proto-Oncogene Mas
Cell Line, Tumor
Gene Expression Regulation, Neoplastic
DNA Copy Number Variations
Algorithms
Gene Expression Profiling

Source PubMed

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
U10 CA180886NCI NIH HHSUnited StatesU10CA180886PubMedNIH RePORTER
U10 CA180899NCI NIH HHSUnited StatesU10CA180899PubMedNIH RePORTER

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References57

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
128,561,664Data Commons to Support Pediatric Cancer Research.Am Soc Clin Oncol Educ Book2017https://conductscience.org/library/papers/28561664PubMed
220,516,441Accumulation of segmental alterations determines progression in neuroblastoma.J Clin Oncol2010https://conductscience.org/library/papers/20516441PubMed
331,375,807Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype.Nat Biotechnol2019https://conductscience.org/library/papers/31375807PubMed
434,236,408Association Between Participation in Clinical Trials and Overall Survival Among Children With Intermediate- or High-risk Neuroblastoma.JAMA Netw Open2021https://conductscience.org/library/papers/34236408PubMed
529,972,784Integrative Bayesian Analysis Identifies Rhabdomyosarcoma Disease Genes.Cell Rep2018https://conductscience.org/library/papers/29972784PubMed
628,176,294The Bayesian New Statistics: Hypothesis testing, estimation, meta-analysis, and power analysis from a Bayesian perspective.Psychon Bull Rev2018https://conductscience.org/library/papers/28176294PubMed
722,367,537Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genes.Nature2012https://conductscience.org/library/papers/22367537PubMed
817,586,306Neuroblastoma.Lancet2007https://conductscience.org/library/papers/17586306PubMed
910,561,284Molecular biology of neuroblastoma.J Clin Oncol1999https://conductscience.org/library/papers/10561284PubMed
1035,217,309Combining selinexor with alisertib to target the p53 pathway in neuroblastoma.Neoplasia2022https://conductscience.org/library/papers/35217309PubMed

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.

PMIDTitleJournalYearIn Papers
42,272,085A Bayesian-Based Integrative Bioinformatics Analysis Nominates Oncogenic Drivers in Neuroblastoma.Clin Transl Sci2026https://conductscience.org/library/papers/42272085

Source PubMed

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ALK238PubTator's text mininghttps://conductscience.org/library/genes/238NCBI Gene
MDM24,193PubTator's text mininghttps://conductscience.org/library/genes/4193NCBI Gene
MYCN4,613PubTator's text mininghttps://conductscience.org/library/genes/4613NCBI Gene
XPO17,514PubTator's text mininghttps://conductscience.org/library/genes/7514NCBI Gene

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42272085

GET https://conductscience.org/api/papers/v1/42272085/references?page=2